-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WH+2zvYyFvSdrge2933/5J7AM7W0BwZXgtTBv/IaSACWtZ3en1LmEDaLyLpNNxft gupy466kOXc/1xdOklSDRQ== 0000849043-07-000004.txt : 20070110 0000849043-07-000004.hdr.sgml : 20070110 20070110100227 ACCESSION NUMBER: 0000849043-07-000004 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070101 FILED AS OF DATE: 20070110 DATE AS OF CHANGE: 20070110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dill Jeffrey CENTRAL INDEX KEY: 0001385709 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18311 FILM NUMBER: 07522063 BUSINESS ADDRESS: BUSINESS PHONE: 203-315-4660 MAIL ADDRESS: STREET 1: 35 NE INDUSTRIAL ROAD CITY: BRANFORD STATE: CT ZIP: 06405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROGEN CORP CENTRAL INDEX KEY: 0000849043 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222845714 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: 2034888201 MAIL ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 3 1 edgar.xml PRIMARY DOCUMENT X0202 3 2007-01-01 0 0000849043 NEUROGEN CORP NRGN 0001385709 Dill Jeffrey 35 NE INDUSTRIAL RD BRANFORD CT 06405 0 1 0 0 VP and General Counsel Common Stock 1015 I 401(k) Plan Stock Options (Right to Buy) 6.75 2007-03-01 2016-03-01 Common Stock 20000 D Stock Option (Right to Buy) 5.78 2007-12-15 Common Stock 2879 D Between March 1, 2006 and December 31, 2006, the reporting person acquired 1,015 shares of common stock under the Neurogen Corporation 401(k) plan. Option was granted under an employee stock option plan, for no consideration. On 3/1/2006 the reporting person was granted an option to purchase 20,000 shares pursuant to the Issuer's Amended and Restated 2001 Neurogen Corporation Stock Option Plan. The options vest in 5 equal annual installments and expire 10 years from grant date. On 12/15/2006 the reporting person was granted an option to purchase 2,879 shares pursuant to the Issuer's Amended and Restated 2001 Neurogen Corporation Stock Option Plan. The options vest in 4 equal annual installments and expire 5 years from each vesting date. by Stephen Davis 2007-01-10 EX-24 2 poajd.htm 
POWER OF ATORNEY



The undersigned hereby appoints Stephen R. Davis, EVP and Chief

Operating Officer of Neurogen Corporation, his or her attorney-in-fact and agent in

any and all capacities to execute for and on his or her behalf filings with the

Securities and Exchange Commission on Forms 3,4 or 5 pursuant to Section 16

of the Securities and Exchange Act of 1934, as amended, to the extent that such

filings relate to the undersigned's status as a director or officer of Neurogen

Corporation. The undersigned further appoints Stephen R. Davis his or her

attorney-in-fact and agent to execute any and all amendments to such filings as

such attorney-in-fact and agent deems appropriate. The undersigned hereby

grants to such attorney-in-fact and agent full power and authority to do and

perform each and every act necessary or desirable as the undersigned could do in

person, hereby ratifying and confirming all that such attorney-in-fact and agent

may lawfully do or has done by virtue hereof.



This Power of Attorney shall become effective as of January 8,

2007.
-----END PRIVACY-ENHANCED MESSAGE-----